For the first time in history, doctors have successfully slowed Huntington’s disease, one of the most devastating genetic conditions known to medicine. As of yesterday, clinical trials show the disease’s progression was reduced by an astonishing 75% after treatment.
What Is Huntington’s Disease?
Huntington’s is a rare genetic disorder that gradually destroys brain cells. Symptoms usually begin in a person’s 30s or 40s and include:
Declining memory and thinking skills (similar to dementia)
Uncontrolled movements (similar to Parkinson’s)
Muscle weakness and difficulty speaking or swallowing
The disease is caused by a mutation in the huntingtin gene. The huntingtin gene encodes the huntingtin protein, which normally transports materials within cells, protects neurons from damage, regulates gene expression, and helps maintain cellular structure. But when the huntingtin gene is mutated, the protein it produces becomes toxic. Instead of protecting neurons, it slowly damages and kills them. Over time, this leads to shrinking areas of the brain, causing the movement problems, cognitive decline, and behavioral changes that define Huntington’s disease. If one parent carries the mutation, there’s a 50% chance their children will inherit it. Once symptoms appear, Huntington’s typically leads to death within 15–20 years.
The New Treatment
The therapy is a form of gene therapy delivered through highly precise brain surgery lasting around 15 hours. Here’s how it works:
Doctors insert a harmless virus carrying a specially designed piece of DNA deep into the brain.
The virus delivers instructions to neurons, telling them to produce microRNA, which are tiny molecules that switch off the faulty huntingtin gene.
As a result, production of the toxic protein drops and neurons are protected from further damage.
Essentially this is reprogramming brain cells to save themselves.
The Results
The trial included 29 patients, and after three years the outcomes were groundbreaking. The treatment slowed disease progression by 75% compared to the expected decline, and tests showed signs of fewer dying brain cells, measured by reduced neurofilaments in spinal fluid. Some patients even maintained mobility and independence far beyond expectations. Researchers say these results could translate into decades of good quality life, compared to the rapid decline normally expected with the disease.
What Comes Next
This therapy still faces several challenges. It requires highly specialized neurosurgery, some patients experienced inflammation (though it was manageable), and the cost is expected to be high, like most other advanced gene therapies.
On a better note the treatment may only need to be administered once for life since neurons do not regenerate like skin or blood cells. Researchers are now planning trials for people who carry the gene but have not yet developed symptoms, raising the possibility that Huntington’s could one day be prevented entirely.
Why This Matters
Around 75,000 people currently live with Huntington’s in the US, UK, and Europe and many more are at risk due to family history. For decades, there was no treatment that could slow or stop the disease, only medications to manage symptoms.
This breakthrough marks the first real progress toward changing that reality and highlights the potential of emerging genetic treatments. Huntington’s could just be the beginning.